Investing in early-stage companies through CENITZ involves significant risk, including the total loss of capital. These opportunities are intended for experienced investors who understand the high-risk nature of startup investing. Past performance is not a reliable indicator of future results.CENITZ does not provide any guarantee of returns and cannot be held liable for the success or failure of any individual investment. Investors are strongly encouraged to perform their own due diligence and to diversify across multiple investments as a way to mitigate potential losses Participation in CENITZ club deals is not a public offering and is strictly reserved for professional or qualified investors, as defined under applicable laws and regulations.
We only share deals we invest in, with a carried indexed on performance.
100%
We invest in every single deal we share
>50%
Of our comittee must accept the deal for it to go through
15 - 20%
Carried indexed on performance
Modern tools to pick your deals.
Through an inhouse developped investment platform
Step 1
Subscribe to our platform
Step 2
Receive deals with investment note directly in your inbox
Step 3
Choose whether to invest or not, with a 100% online investment process
We are industry professionals
A team composed of the founder of seed fund Pi2, along with the co-founder of a leading financial advising firm Impulse Corporate Finance.
Fred Picq, Partner
Fred has been Head Trader for over 10 years in NYC and Geneva at Ziff Brothers Investments, one of the world's biggest Family Offices. He then founded venture capital fund Pi2 driven by his passion for technology and entrepreneurship. He is visionary, agile and creative.
Clovis Tuffier, Partner
Clovis co-founded M&A firm Impulse CF where he has been focusing on technology transactions for high-growth businesses. He is adept at leadership, and has a forward-looking approach,with a keen understanding of market trends and the dynamic landscape of the Venture Capital ecosystem.
Andrea Baridon, Associate
As a valuable member of CENITZ, Andrea finds resonance in the club deal's entrepreneurial spirit, purposeful focus, and commitment to fostering innovation. By leveraging his strategic acumen, he brings a unique perspective when evaluating new investment opportunities.
If they say no, it's no.
Meet our insiders, who curate every deal
Charles Tétard
Managing Partner and cofounder of Impulse CF, completed more than 40 transactions
Olivier Edwards
Senior Counsel & Laywer, Orrick, member of Technology Companies Group, co-founder European Bureau of SV
Richard Tuffier
President, Buy for Good, ex MD ODDO BHF, Business Angel
Niels Court-Payen
President & Co-founder, A Plus Finance (managing $1bn+), ex PAI – Paribas Affaires Industrielles
Hervé Digne
Co-founder Post Advisors, CEO Postmedia Finance, President Manifesto, ENA & Sciences Po
Bernard Grouchko
Founder GL trade (exit 2008), ex-mayor of Le Vesinet, founder Green Recovery
Reimbursement Policies Are Stifling Innovation in European Healthcare
October 1, 2024
English
For healthcare startups, reimbursement is the main gateway to revenue and the ability to scale. Without clear, predictable reimbursement processes, startups are hesitant to invest in expensive research and development.
In Healthcare, there are many different ways to impact investing. Not the same goals, not the same reasons, not the same ambitions. The potential for positive change is infinite, let's delve into these ways.
Democracy at Risk: The Rising Threat of Tech Giants
November 29, 2023
English
In an era where technology dictates pace, the GAFAM giants — Google, Amazon, Facebook, Apple, and Microsoft — & company are becoming the game itself. Are they edging out the role of nation-states?
High-Tech AI Brains vs Timeless Beauty of Human Hands
November 1, 2023
English
Embark on a thrilling journey through the evolution of technology.This story unfolds starting from the pioneering breakthroughs of early physicists to the awe-inspiring realm of AI.
Le retour des Pigeons: avis aux fondateurs de startups
December 1, 2022
French
Alors qu’une grande part de la valeur créée par l’écosystème provient des fondateurs de startups, ceux-ci sont souvent lésés lors des multiples tours de financement qui adviennent.
Le secteur de la Medtech (ou technologie médicale) se compose de 2 secteurs principaux: les appareils médicaux et les diagnostics. Les appareils médicaux (seringue, cathéther, implant…) constituent la catégorie historiquement la plus importante (>90%).
.png)
.png)
.png)
.png)
.png)
.png){kind=small}
.jpg)
